Annual Congress Vienna 2012

Saturday, 01.09.2012
Sunday, 02.09.2012
Monday, 03.09.2012
Tuesday, 04.09.2012
Wednesday, 05.09.2012

Citations should be made in the following way: Authors. Title. Eur Respir J 2012; 40: Suppl. 56, abstract number.



Treatment of lung cancer

Oral Presentation
Chairs: A.P. Meert (Brussels, Belgium), F. Gamarra (Munich, Germany)
Bevacizumab (Avastin®) aerosol therapy (AT) inhibits primary and metastatic tumor growth in a murine model with human non-small cell lung cancer (NSCLC)
Y. Schwarz, A. Starr, A. Litinsky, L. Israeli, O. Merimsky (Tel-Aviv, Israel)
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
Definitive radiation therapy for elderly patients with stage III NSCLC not candidates for combined chemoradiation
K. Sigel, L. Lurslurchachai, G. Mhango, E. Halm, M. Bonomi, J. Wisniveksy (New York, Dallas, United States Of America)
Congress or journal article abstract
Congress or journal article abstract
Histology as a potential clinical predictor of outcome in advanced non-small cell lung cancer (NSCLC) treated with vinorelbine and mitomycin (VM) combination chemotherapy
T. Wibmer, T. Berghmans, C. Kropf, J.J. Lafitte, K.M. Stoiber, M. Paesmans, S. Ruediger, A. Scherpereel, I. Blanta, W. Rottbauer, J.P. Sculier, C. Schumann (Ulm, Germany; Brussels, Belgium; Lille, France)
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
LATE-BREAKING ABSTRACT: A mRNA signature predicts outcome of patients (pts) with advanced non small cell lung cancer (NSCLC) treated with cisplatin (C) and vinorelbine (V): A ELCWP prospective study
T. Berghmans, L. Willems, M. Paesmans, L. Ameye, J. J. Lafitte, A. P. Meert, A. Scherpereel, A. Cortot, C. Mascaux, I. CsToth, T. Dernies, N. Leclercq, J. P. Sculier (Brussels, Gembloux, Belgium; Lille, France)
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
Combination of erlotinib and bevacizumab in non small cell lung cancer patients
E. Boutsikou, T. Kontakiotis, P. Zarogoulidis, P. Pataka, K. Zarogoulidis (Thessaloniki, Greece)
Congress or journal article abstract
Congress or journal article abstract
TTF-1 for prediction of response to chemotherapy in patients with locally advanced or metastatic small cell lung cancer (SCLC)
D. Misch, J. Kollmeier, T. Blum, S. Griff, C. Boch, T. Weiss, C. Crolow, W. Grüning, T. Mairinger, T. Bauer (Berlin, Germany)
Congress or journal article abstract
Congress or journal article abstract
Primary lung cancer treated using radiofrequency ablation – One year outcome data
F. Kamal, J. Beeson, S. Kaul, S. Stirling, S. Mattison, J. Tennant, P. Normahani, P. Dalal (London, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract
Prognosis of patients with a lung cancer admitted in intensive care unit
G. Rousseau-Bussac, D. Margetis, A. Lino, A. Galbois, S. Phin-Huynh, E. Maury, C. Chouaid (Paris, France)
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation